NCTTRAC and TDEM have partnered
with MPP Infusion to create statefunded
infusion sites in Irving and in Fort
Worth. These sites will accept patient
referrals from healthcare providers
across the region to help administer
COVID therapeutics quickly and safely
with the ultimate goal of preventing
patients from needing hospitalization.
Patients must meet at least one of the
• ≥ 65 years of age
• BMI ≥ 35
• Has chronic kidney disease, diabetes, or
• Currently receiving immunosuppressive
• ≥ 55 years of age AND
o Cardiovascular disease, hypertension,
or chronic obstructive pulmonary
disease/other chronic respiratory
Additionally, patients must meet ALL of the
• COVID-positive & within 10 days of
• Not asymptomatic and has mild to
• Not hospitalized due to COVID-19
• Does not require oxygen therapy due to
COVID-19 and has SpO2 ≥ 94% on room
• If pregnant, patient must be cleared with
• Has not received COVID-19 vaccine in
last 90 days
COVID-19 Infusion Centers
• There are currently 2 sites – 1 in Fort Worth and 1 in Irving
• Patients must be referred by a physician, nurse practitioner, or
PA – patients cannot refer themselves
• There is no “walk-in” availability; all treatments must be
scheduled in advance
• Infusions utilize monoclonal antibody treatments including
Bamlanvimab or the Regeneron Cocktail (Casirivimab &
• This is a state-funded operation – there is no cost to the patient
I am a Physician – How Do I Refer a Patient for Infusion?
• Fill out the MPP Infusion COVID Antibody Therapy Order Form
o If you do not have this form, call 855-478-1528 to get it
• Submit the completed form to MPP Infusion
o By Fax: 407-636-9659
o By Email: PatientCareNavigators@mppinfusion.com
• MPP Infusion will reach out to the patient to schedule an
Q: What documentation do I need to get the infusion?
A: You will need to provide a photo ID, such as a driver’s license, passport,
work ID, parish ID, library card, or other form of photo ID.
Q: Who can refer a patient to these infusion centers?
A: Physicians, Nurse Practitioners, or Physician’s Assistants operating in Trauma
Service Area E. There are no residency restrictions, nor are there limits on
which physicians can refer or how many patients can be referred. Referrals
can come from hospitals, Freestanding EDs, and physician offices.
Q: How is patient consent obtained?
A: MPP Infusion acquires HIPPA consents, consents to treat and completes an
initial assessment. MPP Infusion requires a referral form and documentation
from the visit outlining that the patient is at high risk and a prime candidate
Q: What happens after a physician submits a patient referral?
A: MPP Infusion will contact the patient and the referring provider to conduct
an initial assessment to ensure the disease has not progressed substantially
and to schedule the infusion appointment.
Q: What is the daily capacity of the regional infusion centers?
A: The Irving and Fort Worth sites can each do 50 treatments in a 12-hour
Q: Where are these infusion centers getting their supply of treatments?
A: Initial supply of Bamlanivimab came directly from TDEM; initial supply of
the Regeneron Cocktail have come from local hospitals. If your hospital is
willing to share Bamlanivimab, Casiribimab, or Imdevimab with these
regional infusion centers, please contact NCTTRAC_EMCC@ncttrac.org.